Therapeutic Drug Monitoring of Venlafaxine and Impact of Age, Gender, BMI, and Diagnosis
, , , , , , e
18 nov 2020
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Original Paper
Pubblicato online: 18 nov 2020
Pagine: 33 - 37
Ricevuto: 28 feb 2020
Accettato: 24 giu 2020
DOI: https://doi.org/10.2478/afpuc-2020-0005
Parole chiave
© 2019 Krivosova M. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Krivosova, M.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Kertys, M.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Grendar, M.
Bioinformatics Unit of Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Ondrejka, I.
Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Hrtanek, I.
Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Tonhajzerova, I.
Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Sekaninova, N.
Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Mokry, J.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia